@oncology_bg @Lymphomation @theNCI @drdgoldstein @VincentRK @vmontori @Dr_R_Kurzrock This JITC paper finds the following exposure-response for nivolumab across several tumor types: https://t.co/MHoROwTWQh https://t.co/iNwazv1wzz
1,237 followers
1,853 followers
RT @sitcancer: #JITC Research: #Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy https://t…
19,274 followers
#JITC Research: #Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy https://t.co/jgrGtDd1yV
438 followers
RT @sitcancer: #JITC Research: #Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy https://t…